CTT Pharma Files Trademark Names Pacific Blue and Blue Rush
Tampa, Florida, United States – TheNewswire – June 9, 2022 – CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is announcing today that we have recently filed two federal trademark names, Pacific Blue and…
Read More
CTT Pharma Strengthens Caffeine Patent in USA
Tampa, Florida, United States - TheNewswire - April 27, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is announcing today that we have recently filed a patent application encompassing Caffeine-containing orally…
Read More
CTT Pharma Strengthens Vitamin Patent in USA
Tampa, Florida, United States - TheNewswire - April 25, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is announcing today that we have recently filed a patent application encompassing vitamin-containing orally administrable…
Read More
CTT Pharma Update On European Patent
Tampa, Florida, United States - TheNewswire - April 13, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) has made progress on numerous patents that are pending. The latest correspondence from the…
Read More
CTT Pharma signs LOI with Black Rose Organics, a Canadian Licensed Producer
Tampa, Florida, United States - TheNewswire - April 12, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) has signed a Letter of Intent with Black Rose Organics for a 50/50 joint…
Read More
CTT Pharma Announces Mexico Patent Allowed
Tampa, Florida, United States – TheNewswire - March 30, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) has expanded its reach into additional international markets with a successful patent application of…
Read More
CTT Pharma Announces Australia Patent Approval
Tampa, Florida, United States - The Newswire - March 23, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) has expanded its reach into additional international markets with a successful patent application…
Read More
CTT Pharma Announces South Africa Patent Approval
Tampa, Florida, United States – TheNewswire - March 22, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) has expanded its reach into additional international markets with a successful patent application of…
Read More
CTT Pharma Announces CEO and New Corporate Strategy
Tampa, Florida, United States – TheNewswire - March 14, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is pleased to announce the appointment of Ryan Khouri as its new CEO. Mr…
Read More
CTT Pharmaceutical Corporate Update
Tampa, Florida, United States – TheNewswire - February 28, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) announced today that Cam Birge has stepped down as CEO. Cam was an instrumental…
Read More
CTT Enters into Business Development Partnership with 3 Rivers Biotech
Partnership Further Advances Aggressive Business Development Strategy Pre-eminent Tissue Culture Company Provides Access to Substantial Network of CPG Companies 3 Rivers’ Technology Transfer Capabilities Expand CTT’s Operational Capacity Hamilton, Ontario,…
Read More
CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory Board
Hamilton, Ontario, Aug. 27, 2020 - CTT Pharmaceutical Holdings, Inc., (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that…
Read More
CTT Pharma Strengthens Board and Management Team
Company represented at Bryan Garnier Cannabis Conference Hamilton, Ontario, Nov. 27, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC: CTTH), an innovative life sciences company…
Read More
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces National Patent Applications Worldwide for Orally Administrable Nanonized Opioids, Cannabinoids, Nutraceuticals and Other Pharmaceutical Agents
Includes All Markets in which Aurora Cannabis Currently Operates or Contemplates Future Operations Hamilton, Ontario, Jan. 15, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC:CTTH), an innovative life…
Read More
The Berkshire Hathaway of Marijuana Stocks Is Smoking Hot…Thanks to Other Marijuana Stocks
Canada-based Aurora Cannabis Inc. tripled its revenue thanks to bigger weed sales in the final quarter of its fiscal year, but the pot producer’s profit gains were mostly the result…
Read More
Aurora Cannabis Converts CTT Pharmaceuticals Debenture into 9% Equity Position
September 11, 2018 10:08 ET | Source: CTT Pharmaceutical Holdings, Inc. Companies Working on Regulatory Approval for CTT’s Sublingual Wafer Technology Hamilton, Ontario, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CTT…
Read More
CTT Pharmaceuticals Appoints Aurora Nominee Dr. Jason Dyck to Board of Directors
HAMILTON, Ontario, July 12, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel…
Read More
CTT Pharmaceuticals Announces Executive Management Change
Cam Birge becomes President and Director, Dr. Pankaj Modi remains as CEO and Chief Science Officer HAMILTON, Ontario, June 07, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company”…
Read More
Aurora Cannabis Inc (TSE:ACB) Makes Another Medical-Based Cannabis Investment
Aurora Cannabis Inc (TSE:ACB) (OTCQB:ACBFF) (FRA:21P) has made another medical-based cannabis investment—this time on delivery systems. This continues a patently obvious plan to dominate the medical cannabis space as the liberalization…
Read More
Aurora Cannabis Makes a Bigger Move into Pharma Tech
Aurora Cannabis Inc. (TSX:ACB) has acquired an ownership stake in CTT Pharmaceutical Holdings Inc SmallCapPower | May 24, 2018: Aurora Cannabis Inc. (TSX:ACB) Tuesday announced that it has acquired an…
Read More
Aurora Cannabis Makes Strategic Investment in CTT Pharmaceutical
Aurora Expands Exclusive Access to CTT's Product and Development Pipeline TSX: ACB OTC: CTTH EDMONTON, May 22, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB:…
Read More
CTT Pharmaceutical Holdings, Inc. Provides Corporate Update with Emphasis on Patent Portfolio
HAMILTON, Ontario, May 15, 2018 (GLOBE NEWSWIRE) -- HAMILTON, Ontario, May 16 2018 (GLOBE NEWSWIRE)—CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP…
Read More
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical
Convenient, High Bioavailability, Rapid Onset of Action Drug Delivery TSX: ACB TSX: CMED OTC: CTTH EDMONTON, SASKATOON and HAMILTON, ON, April 16, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX:…
Read More
Medical marijuana may reduce opioid use a little
Legalizing medical cannabis might offer an alternative to narcotics to treat pain Making medical marijuana available might help reduce opioid prescriptions, researchers reported Monday. They found states that legalized…
Read More
Aurora Acquires CanniMed and Commences Integration
TSX: ACB EDMONTON, March 15, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has completed its initial take up…
Read More
Aurora Cannabis Announces Final Regulatory Approval for CanniMed Therapeutics Acquisition
Intends to Take-Up as soon as Minimum Tender Condition is Met TSX: ACB EDMONTON, Feb. 28, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN:…
Read More
UPDATE–CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents
Patent Grant Provides the Company with a Disruptive Method of Delivering Active Therapeutic Molecules Orally for Absorption within Seven Minutes and Expands the Company’s Patent Portfolio to five Issued (3…
Read More
Israel Scientific Study: Cannabis Safe and Effective for Regular Use in the Elderly; Can Decrease the Use of Other Prescription Medicines, Including Opioids
A new published clinical study out of Israel offers scientific evidence that the therapeutic use of cannabis can be a safe and effective treatment for elderly people, and is often…
Read More
Aurora Announces Q2 Fiscal 2018 Results
Accelerated Revenue Growth, Lower Per Gram Costs to Produce and Sell, Continued Expansion, Diversification and Differentiation TSX:ACB EDMONTON, Feb. 8, 2018 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX:…
Read More
AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION
TSX:ACB TSX:CMED EDMONTON and SASKATOON, Feb. 6, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. ("CanniMed") (TSX: CMED) today announced…
Read More
Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction
Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction Canada NewsWire EDMONTON and SASKATOON, Jan. 24, 2018 CanniMed's Board and Special Committee Support Aurora's Offer of Shares and…
Read More
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces U.S. Patent for Therapeutic Composition for Treating Psoriasis with Cannabidiol and Corticosteroids
HAMILTON, Ontario, Jan. 10, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel drug delivery systems designed…
Read More
CTT Pharmaceuticals Holdings, Inc. Provides Corporate Update
TheNewswire / Hamilton, ON, November 14, 2017 CTT Pharmaceuticals Holdings, Inc., an innovative life sciences company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes and experiences,…
Read More
Marjiuana bill to unleash a sea change in public policy not seen since the 1930s
OTTAWA — It’s nothing short of a sea change in public policy, one with profound implications for everything from Canadian culture and health to border security, road safety and even…
Read More
Aphria takes medical marijuana model to U.S. with $25 million investment in Florida
Medical marijuana producer Aphria Inc. is expanding into the lucrative U.S. market with an initial $25 million investment to set up shop in Florida, which recently legalized pot for medical…
Read More
Meet the NFF: New Group to Lobby Trump, Congress on Cannabis
Several leading cannabis companies across the United States have banded together to form a political advocacy group aimed at protecting the legal cannabis trade. The group includes major mainstream cannabis players and a…
Read More
Marijuana ETF ‘the most scrutinized fund that we’ve ever launched,’ Horizons CEO says
Canadians will be able to invest in a basket of marijuana companies when the first marijuana exchange-traded fund launches next week, helping investors diversify their exposure to the volatile and…
Read More
Liberals to announce marijuana will be legal by July 1, 2018
The Liberal government will announce legislation next month that will legalize marijuana in Canada by July 1, 2018. CBC News has learned that the legislation will be announced during the week…
Read More
Independent Laboratory Analysis Confirms CanniMed Medical Cannabis Products Free from Pesticides, Fungicides, and Plant Growth Regulators
February 22, 2017 03:37 PM Eastern Standard Time SASKATOON, Saskatchewan--(BUSINESS WIRE)--CanniMed Therapeutics Inc. (TSX: CMED) proactively commissioned an independent laboratory analysis of the Company’s herbal cannabis products to test for…
Read More
CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer
Stoney Creek, Ontario : Today, CanniMed Therapeutics Inc. (TSX: CMED) and CTT Pharmaceutical Holdings Inc. (OTC Pink: CTTH) have entered into a definitive contractual relationship for the licensing of CTT’s…
Read More
CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer
SASKATOON, Saskatchewan & STONEY CREEK, Ontario--(BUSINESS WIRE)--Today, CanniMed Therapeutics Inc. (TSX: CMED) and CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) have entered into a definitive contractual relationship for the licensing of CTT’s…
Read More
CanniMed Therapeutics, Cronos Group, Aphria, And Canopy Growth Shares Ignited By Germany’s Medical Marijuana Law
CanniMed Therapeutics Inc (TSE:CMED)(OTCMKTS:CMMDF)(FRA:0GB) , Cronos Group(CVE:MJN)(OTCMKTS:PRMCF) , Aphria Inc (CVE:APH) (OTCMKTS:APHQF) andCanopy Growth Corp (TSE:CGC) (OTCMKTS:TWMJF) (FRA:11L1) are among the most heavily traded stocks on their respective Canadian exchanges in the last few…
Read More
Canopy Growth’s $430M takeover of Mettrum would be biggest-ever deal in global marijuana business
Canadian medical marijuana producer Canopy Growth Corp.’s $430 million deal to buy Mettrum Health Corp. will go down as the biggest takeover in the history of the burgeoning global marijuana…
Read More
John Ivison: Marijuana report to urge Liberals to strike at the black market
The key recommendation of the panel charged with outlining the framework for Canada’s legal marijuana regime is that the system should be geared toward getting rid of the $7-billion-a year…
Read More
Marijuana wins big on election night
Voters in California, Massachusetts and Nevada approved recreational marijuana initiatives while an initiative in Maine was leading in the polls Wednesday morning. The 2016 election has proved to be the…
Read More
After Election Day, access to marijuana likely to reach all-time high across nation
California voters will decide Nov. 8 whether to legalize marijuana for recreational use. Many pot farmers have yearned for the legitimacy and respectability of legalization. But they also fear Proposition…
Read More
CTT Pharmaceutical Holdings to License to CanniMed Ltd. Novel Cannabis Orally Dissolvable Thin Film (ODF) Wafer Drug Delivery Technology for North American Markets
Ottawa/Saskatoon : CanniMed Ltd. has entered into a letter of intent with CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) to license CTT’s Orally Dissolvable Thin Film (ODF) Wafer technology. This industry-first collaboration…
Read More